Menu

Syndax Pharmaceuticals, Inc. SNDX

Full chart Compare
Set alert

Price alert · SNDX

All alert types
9.54 USD +0.17 (+1.81%)

At closeNov 6, 2026, 5:43 PM EST

9.70 +0.16 +1.68%

After hours · Nov 6, 5:43 PM ET

9.22 Day range 9.78
9.22 52-week range 25.59
YTD
-54.59%
1 year
-35.06%

Revenue & Expenses

Other Income → Expenses: $21.45MExpenses → Selling, General & Admin: $179.68MExpenses → Research & Development: $258.78MExpenses → Interest Expense: $33.78MGross Profit → Expenses: $165.38MRevenue → Gross Profit: $165.38MRevenue → Cost of Revenue: $6.97MNet Loss → Expenses: $285.42MOther Income$21.45MGross Profit$165.38MNet Loss$285.42MCost of Revenue$6.97MExpenses$472.25MSelling, General & Admin$179.68MResearch & Development$258.78MInterest Expense$33.78MRevenue$172.35M

Latest period ending Dec 31, 2025 · select a line to chart its full history

Annual income statement

SNDX annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
172.35M23.68M00139.71M
172.35M23.68M00139.71M
6.97M826.00K000
165.38M22.85M00139.71M
438.47M362.53M229.95M151.76M113.49M
258.78M241.65M163.03M118.50M88.25M
179.68M120.88M66.92M33.26M25.24M
-273.08M-339.67M-229.95M-151.76M26.22M
33.78M4.93M208.00K3.14M1.90M
-285.42M-318.76M-209.36M-149.34M24.93M
-285.42M-318.76M-209.36M-149.34M24.93M
-285.42M-318.76M-209.36M-149.34M24.93M
-285.42M-318.76M-209.36M-149.34M24.93M
-3.29-3.72-2.98-2.460.48
-3.29-3.72-2.98-2.460.48
-3.29-3.72-2.98-2.460.46
-251.64M-313.83M-209.15M-146.20M26.82M
-251.64M-313.83M-209.15M-146.20M26.82M
86.63M85.62M70.37M60.76M52.06M
86.63M85.62M70.37M60.76M53.62M